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tion. Sodium channel blockers and higher ECG lead positioning have been shown to 
unmask the ECG marker. But the sensitivity and specificity of each provocation alone 
and in combination is unknown. Thus, we studied 21 SUDS males (age 44 + 13 yrs), who 
had no heart disease with normal ECG and 8 matched normal males. Eleven of the 21 
SUDS patients (pts) had VF and the other 10 had SUDS like symptoms or syncope; 19 of 
the 21 pts had inducible VT. All underwent conventional ECG (V1-3 at the 4 th intercostal 
space [ICS]) and the higher ICS lead positioning (V1-3 at the 2 nd and 3 rd ICS) at base- 
line, during Ajmatine (Aj) 1 mg/kg and during procainamide (Proc) 10 mg/kg (each drug 
was given 24 hrs apart). Our results show that higher ICS lead positioning and Aj or Proc 
alone modestly increased the sensitivity of unmasking the abnormal ECG pattern, the 
best outcome is when combining the drug with higher lead positioning. None of the nor- 
mal control subjects had an abnormal ECG pattern with any of these provocative maneu- 
vers, alone or in combination. Conclusion: Sodium channel blockers, in combination with 
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higher lead (V1-V3) positioning, have 100% specificity and over 75% sensitivity for the 
diagnosis of SUDS or Brugada syndrome. And Aj is more sensitive than Proc (95% ver- 
sus 76%). 
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10:30 a.m. 
859-1 Prospective Evaluation of Characteristic 
Echocardiographic Imaging Signature Associated With 
Successful Ablation of Inappropriate Sinus Tachycardia 
Jian-fano Ran. Francis E. Marchlinski, David J. Caltans, University of Pennsylvania, 
Philadelphia, Pennsylvania. 
Background: A characteristic intracardiac echocardiographic (IE) signature suggesting 
transmural/epicardial damage is associated with successful heart rate reduction during 
anatomically-guided ablation of inappropriate sinus tachycardia (IST). This study is to fur- 
ther evaluate if this may be used as an appropriate endpoint for procedural success. 
Methods: Detailed on-line videotape IE (9MHz, 9Fr) imaging monitoring was performed 
in 5 pts (all women, age 35-+13yrs) with IST. Radiofraquency (RF) ablation was anatomi- 
cally-based and targeted mainly the superolateral crista terminalis (CT) guided by IE. 
Lesions were created with 20-50w for up to 2 minutes using an 8-ram tip electrode. 
Echodensity changes reaching to the epicardium with the development of a complete lin- 
ear echo-free space (following expansion of wall swelling around the CT and superior 
vena cava [SVC]) and the ablation number (time) associated with heart rate reduction 
were carefully assessed during the procedure. Results: Successful heart rate reduction 
(from 112_+54 to 76~8 beats/rain) was achieved in all 5 pts and required 38_+12(range 28 
to 67) RF applications. A transient heart rate reduction started when an incomplete linear 
(segmental) echo-free space developed at the 22nd~14th lesion. With further IE guided 
lesion deployment, a complete linear echo-free space developed finally covering whole 
superolateral CT area. This indicated appropriate endpoint when sustained heart rate 
reduction was observed in all 5 pts (4/5 pts with the p wave in lead III changed from a 
positive to a fiat or negative direction). Craters and thrombus formation were observed 
within the lesions, No other procedural related complications, such as SVC-RA junction 
narrowing >50% or pericardiat effusion, were identified. No recurrence for symptoms 
from ablated IST was observed over a foUowup period of 2 to 9 months. Conclusion: A 
characteristic IE imaging signature of the development of a complete echo-free space at 
CT may provide an appropriate endpoint for procedural success of IST ablation. 
10:45 a.rn. 
859-2 Reso lu t ion  of  Increased Pulmonary Vein Flow Velocity 
Following Radio Frequency Ablation for Atrial 
Fibrillation: A Doppler Color Flow Imaging Follow-Up 
Jian-fano Ran, David J. Callans, Francis E. Marchlinski, University of Pennsylvania, 
Philadelphia, Pennsylvania. 
An increased flow velocity reflects ostial/lumen narrowing in the ablated pulmonary vein 
(PV) following catheter ablation for atrial fibrillation (AF). The present study was to char- 
acterize the magnitude and time course of flow velocity changes using an AcuNav ultra- 
sound catheter (UC) during repeat procedures targeting the same PV and evaluate the 
flow velocity response to the repeat ablation. Methods: Out of 174 pts with AF undergo- 
ing LA ablation (78 had UC PV flow study) involving at least one PV ostium, 18 (16men; 
age 53_+9yrs) had repeat ablation (upto 52°C,40W,90sec) for recurrent AF (9.5±7months 
followup), The peak velocity (V, cm/s) of PV ostial flow was measured Pre- and Post-abla- 
tion. Results: V was assessed in 28/31 PVs (initial) previously targeted with followup 
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measurement at intervals of 3 days (n=2 PVs), I to 3 months (M) (n=6), 4 to 12M (n=15), 
and 13 to 30M (n=5)(Table). The V measured >100cm/s Pre-rapeat ablation only in 2 pts: 
One was 110cm/s at an interval of 3 days (vs. 129cm/s post-initial ablation) and the other 
remained at 137cm/s after 2.9M followup. There was no significant difference for 
increased V following repeat ablation at previously targeted PV (n=17 PVs; 64_+8 Pro- vs. 
118-+28 cm/s Post-) as compared to those of previously non-targetad PVs (n=12; 62+12 
vs. 120-+36). Conclusion: Increased PV ostial flow acutely after lesion deployment 
appears to resolve within 3 months. V of PV flow after repeat ablation of previously tar- 
geted PV is comparable to V of non-targeted or PV with initial ablation. 
Initial Pre- Post- Followup 3 days 1-3M 4-12M 13-30M 
52-+10cm/s 10t+_24 86_+35 71_+33 56-+10 52-+6 
(range 26-63) (73-137) (61-110) (47-137) (37-71) (46-61) 
11:00 a.m. 
859-3 Acute Changes in Pulmonary Vein Flow Do Not Predict  
Chronic Pulmonary Vein Stenosis Following Atrial 
Fibrillation Ablation 
Christooher R. Cole. Nassir E Marrouche, Thomas J. Dresing, Alejandro Peraz-Lugones, 
Krzysztof Balaben, Eduardo Saad, Patrick Tchou, Andrea Natale, Cleveland Clinic 
Foundation, Cleveland, Ohio. 
Background: Electrical isotation of the pulmonary veins with radiofraquency ablation is 
used for the treatment of atrial fibrillation. A serious potential complication of this proce- 
dure is pulmonary vein stenosis. Measurement of the pulmonary vein flow with intrecar- 
diec echo pre- and post-ablation has been advocated as a method of predicting which 
patients will go on to develop chronic pulmonary vein stenosis. However, this hypothesis 
has never been tested. 
Methods; We measured pre- and post-ablation diastolic pulmonary vein flow in each of 
the 4 pulmonary veins using a phased-array intracardiac echo catheter (Accuson) in 47 
patients (age 51±11) undergoing afib ablation. The ostium of each of the pulmonary 
veins was defined using angiography, electrical mapping and the intracardiac echo cath- 
eter. Electrical isolation all 4 pulmonary veins was achieved using a 4-ram cooled-tip 
radiofrequency ablation catheter (Cardiac Pathways). Change in pulmonary vein flow, 
when present, was examined as both an absolute value and as a percentage of the 
baseline flow. All patients underwent spiral computed tomography (CT) scans of the pul- 
monary veins 2 months after the procedure. Stenosis was defined as mild (70%). 
Regression analysis was used to determine the correlation coefficient (r) between pulmo- 
nary vein flow change and pulmonary vein stenosis. 
Results: The average pre-ablation flows for the left superior, left inferior, right superior 
and right inferior veins were 0.56, 0.54, 0.47 and 0.45 m/s respectively. These increased 
to 0.74, 0.67, 0.58 and 0.89 m/s post-ablation. The absolute increase in flow ranged from 
0 to 0.8 m/s. The maximum flow change as a percentage was 200%. Of note, chronic 
stenosis did not occur in either of the patients who had high acute flow changes. Out of 
188 pulmonary veins ablated, the CT scans revealed 2 (1%) with significant stenosis, 5 
(3%) with moderate stenosis and 39 (20%) with mild stenosis of the pulmonary veins. 
The r-value between flow and stenosis was only 0.06 (p=ns). 
Conclusions: Acute changes in pulmonary vein flow assessed by intracardiac echo do 
not appear to be a strong predictor of chronic pulmonary vein stenosis. 
11:15 a.m. 
859-4 Comprehensive and Detailed Analysis of Pulmonary 
Veins, Left Atrial Appendage, and Their Interrelations 
With Gadolinium Enhanced Magnetic Resonance 
Angiogrephy and 3-D Navigation View Analysis 
Lars M. Lickfett, Ritsushi Kato, Henry Halperin, Stephen Sotomon, Tim Dickfeld, Khurram 
Nasir, Glenn Mainingar, Richard Wu, Charles Leng, Georg Juang, Kevin Donahua, 
Gordon Tomaselli, Ronald Berger, Hugh Calkins, Johns Hopkins Hospital, Baltimore, 
Maryland. 
Background: Atrial fibrillation (AF) can be cured by electrical isolation of the pulmonary 
veins (PV). Elimination of PV potentials has been proposed as the optimal endpoint for 
ablation. However, it is often difficult to distinguish PV potentials from far field potentials 
created by the left atrial appendage (LAA) and other structures. The purpose of this study 
was to use magnetic resonance angiography (MRA) to explore the anatomical relation- 
ships between the PV and LAA in patients (pt) referred for focal AF ablation. 
Methods: Breath hold gadolinium enhanced MRA, using a 1.5 T cardiac MR imager 
(GE), was performed in 15 consecutive patients (pt) who underwent catheter ablation of 
focal AF at this institution (4 female,51+13 yrs). 3D reconstructed images of the left 
atrium (LA) and PV were obtained. 3D navigation views were used to determine the dis- 
tance between the LAA and the left PVs. 
Results: In these pt with AF the LA volume was 88.8+~4.6 cc (range 49.2-127.3). The 
left LAA area was 6.2 cm 2 (range 2.2-9.3). The LAA was positioned in close proximity to 
the left superior PV with a distance of 4.8+0.9 mm (range 3.5-6.3) between the ostia of 
these two structures. The distance from the LAA to the left inferior PV was 7.3_+3.5 mm 
(range 3.1-12.9). The PV anatomy was highly variable with one common ostium of the 
left PV, 2 pt demonstrating a shared mouth with a very short neck and two pt demonstrat- 
ing a right middle PV. The overall diameter of the PV ostia was 18.2:~..7 ram. The pattern 
of vein branching was significantly different (p<0.05) between the left and right PVs with 
the 1st branching occurred 23.4_+5.4 mm (range 16.9-33.8) from us in the LSPV, 18_+4.2 
mm (range 13.7-27.1) in the LIPV, 12.7±4.1 mm (range 6.8-23.3) in the RSPV and 
11.2+4 mm (range 5-18.3) in the RIPV. 
Conclusions: The results of this study reveal a close anatomic relationship between the 
left superior pulmonary vein and the left atrial appendage. This may account for the 
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greater amplitude of far field potentials when performing catheter ablation in the left 
superior pulmonary vein. The results of this study also demonstrate that pulmonary vein 
anatomy is highly variable and that a different pattern of branching exists between the 
right and left pulmonary veins. 
11:30 a.m. 
859-5 Randomized Evaluation of the Utility of Intracardlac 
Echocardiogrsphy for AV Node Interventions 
~ ,  David Schwartzman, Atrial Arrhythmla Center, University of Pittsburgh, 
Pittsburgh, Pennsylvania. 
Background: The value of intracardiac echocardiography (ICE) for guiding transvenous 
catheter ablation procedures which target the AV node complex is unclear. Methods: The 
ICE catheter utilized incorporated a rotating transducer operating at 9 MHz (Boston Sci- 
entific). Patients undergoing complete AV node ablation (AVN, n=30) or slow pathway 
ablation (SP, n=10) were randomly assigned to ICE-guided or standard (eg. fluoroscopy/ 
electrogram-guided) technique. In the standard groups, ICE images were recorded but 
were unavailable to the operator for review until after the case. Results: (table shows 
median values; *p<.05 versus compadson group): All procedures were acutely success- 
ful. Total procedure duration, radiofrequency power, and ablation electrode maximum 
temperature were not significantly different. Based on the ICE images, in the standard 
groups the principal reason for individual esion failure was poor/unstable ablation elec- 
trode-endocardial contact. Intraprocedurally, in the AVN cohort 1 patient in the standard 
group required crossover to ICE. During followup (at least 6 months in each patient): in 
the AVN cohort 2 patients in the standard group experienced recurrence of AV nodal con- 
duction; in the SP cohort 1 patient in the ICE group expedencad spontaneous recurrence 
of AV nodal reentry. Conclusions: For catheter ablation or modification of the AV node, 
relative to standard technique the ICE-guided technique reduced fluoroscopy exposure 
and ablation lesion burden. 
AVN-iCE AVN-Standard SP-ICE SP-Standard 
Patients (n) 15 15 5 5 
Fluoro "rime (min) 0.0 * 3.1 0.2 * 5.5 
RF Lesions (n) 1 * 3 1 * 3 
11:45 a.m. 
859-6 Four Vessel Pu lmonary Vein Isolation Guided by Intra- 
Cardiac Echocardiography Without Contrast 
Venography In Patients With Drug Refractory 
Paroxysmal Atrial Fibrillation 
Viiendra Swaruo. Koji Azegemi, Mauricio S. Arruda, Martin C. Burke, Albert C. Lin, David 
J. Wilber, University of Chicago Hospitals, Chicago, Illinois. 
Background: Pulmonary vein (PV) isolation requires accurate definition of PV anatomy. 
Venography is time consuming and increases exposure to contrast and radiation. We 
present our experience with intracardlac echocardiography (ICE) to image and guide 
empiric isolation of all four PV without venography. Methods: 24 pts (age 49±10.6 yrs) 
with refractory paroxysmal atrial fibrillation (PAF) underwent circumferential mapping 
(Lasso, Biosense/Webster) and isolation of all four pulmonary veins with radiofrequency 
ablation. ICE (Acuson) was used to guide transseptal puncture, and determine PV diam- 
eters and flow velocities before and after ablation. During ablation, ICE was utilized to 
monitor catheter positioning. Results: All veins were successfully imaged by ICE and 
electrically isolated as documented by post ablation PV mapping. Mean duration of trans- 
septal catheterization was 134 ± 35 rain and fluoroscopy time was 41.8 -+ 13 min. There 
were only minor changes in PV diameters and flow velocities immediately post proce- 
dure. Spiral CT images at 3 months did not demonstrate PV stenosis or occlusion in any 
pt. No PAF was documented in 19/24 pts (79%) during short-term follow-up 
LtSuperior Lt Inferior Rt Superior Rt Infedor 
PV PV PV PV 
Diameter (cm) Pre 1.4 ± 0.2 1.6 + 0.2 1.7 ± 0.4 1.5 ±0.3 
Post 1.2 + 0.2 1.5 ± .2 1.6 ± 0.4 1.3 + 0.3 
PeekVeloclty(m/sec) Pro 0.56:t:0.15 0.53±0.13 0.56+0.18 0.46+0.09 
Post 0,75 ± 0.3 0.68 ± 0.26 0.59 + 0.15 0.56 + 0.12 
Conclusion: Exclusive use of ICE without venography to guide ablation of all four pulmo- 
nary veins is a feasible and practical strategy. Continuous reel-time guidance of energy 
delivery at the PV ostium may enhance both the safety and effectiveness of 4 vessel iso- 
lation relative to other imaging techniques. 
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1185-103 Associat ion of Angiotenein Convert ing Enzyme Gene 
Polymorphlam With Tachycardia Cardlomyopethy 
Pramod M. Deshmukh, John D. Noti, Mary A. Romanyshyn, Guthrie Clinic, Ltd, Say'e, 
Pennsylvania, Guthrie Research Institute, Sayre, Pennsylvania. 
Background: Insertion/deletion (I/D) polymorphism of angiotensin converting enzyme 
(ACE) gene has been implicated in ischemic and non-ischemic cardiomyopathy. How- 
ever, its relation to tachycardia cardiomyopathy is unknown. 
Methods: Twenty patients with persistent echycardla nd cardiomyopathy with ejection 
fraction (EF) 20 ± 7% showed improvement in EF to 43 ± 9% (p < 0.001) after interven- 
tions for rate control (Group A, tachycardla cardiomyopathy). A separate group of 
patients with a history of atrial arrhythmlas of 16 ± 15 months required interventions for 
rate control but maintained normal EF of 49 ± 5% (Group B, tachycardia without cardi- 
omyopathy). We compared I/D genotype frequency of Group A and B with that of healthy 
normal volunteers (Group C). 
Results: Gene frequency was significantly different in Groups A, B, and C (p < 0.002). 
Group A was significantly different from Group B (p < 0.035) and Group C (p < 0.009). 
Despite improvement, Group A's EF of 43% was significantly lower than Group B's EF of 
49% (p < 0.02). 
Conclusion: I/D poiymorphism of ACE gene may account for cardiomyopathy second- 
ary to tachycardla. 
1185-104 Assessment of Therapeutic Efficacy in 
Neurocardiogenic Syncope: Clomlprsmine Versus 
Isoproterenol Tilt Test 
Gaor?e N. Thendorakis, Dionyssios Leftheriotis, Efthimios G. Uvanis, Panagiota Flevari, 
Elias Zarvalis, Dimitrios T. Kramastinos, Onassis Cardiac Surgery Center, Athens, 
Greece. 
Background: In patients (pts) with recurrent neurocardiogenic syncope (NCS), evaluation 
of therapeutic efficacy by repeated heed-up tilt testing (HUT) with isoproterenot as drug 
challenge is questioned. Clomipramine has also been used dudng HUT for the diagnosis 
of NCS. In this study, we prospectively compared ciomipramine HUT with isoproterenol 
HUT in order to evaluate their relative efficacy in assessing response to treatment. Meth- 
ods: We studied 46 pts (17 men, 29 women, mean aged 36±17 years) with history of 
recurrent NCS and two consecutive positive HUTs (HUTs-I), one with clomipramine and 
the other with isoproperonoL The two tests were performed in a randomized sequence 
and an 24-hour interval was interspersed between them. Our pts were randomly treated 
with fiuoxetine or propranolol for 6 months and then the two HUTs were repeated in the 
same sequence (HUTs-2). We recorded the number of syncopal attacks during the last 6 
months before therapy and during the 6 months of treatment. We also examined whether 
the decrease in syncopal episodes during therapy was associated with the response to 
each of HUTs-2. Results: Fluoxetine and propranolol were equally effective in reducing 
syncopal attacks (4.0~1.8 before therapy vs 1.3±0.8 during therapy for fluoxetine and 
3.8±1.6 vs 1.1±1.5 respectively for propranolol, p:NS). Following therapy, a negative clo- 
mipramine HUT-2 was associated with a greater decrease in syncopal episodes (4.0±1.7 
vs 0.9¢1.2) than a positive clomipramine HUT-2 (3.9±1.3 vs 1.4±1.1), p<0.01. No such 
difference was observed between pts with a negative isoproterenol HUT-2 (3.9±1.2 vs 
1.2±1.1 ) and those with a positive isoproterenol HUT-2 (4.0±1.3 vs 1.0±1.0). Conclusion: 
In patients with NCS, clomipremine*HUT depicts therapeutic efficacy more accuretly than 
isoproterenoI-HUT. his may have important clinical implications. 
1185-105 Prevalence of Self-Reported Syncope: An 
Epidemiologic Study From Olmsted County, MN 
Lin Y. Chen, Win K. Shen, Douglas W. Mahoney, Steven J. Jacobsen, Richard J. 
Rodeheffer, Mayo Clinic, Rochester, Minnesota. 
Background: Although syncope is a common clinical syndrome with significant prognos- 
tic, psychosocial and economic implications, our current understanding of the prevalence 
of syncope is based on a few small studies in the past, and from very selected popula- 
tions. In this study, we estimated the prevalence of syncope in a cross-sectional survey 
of the adult population of OImsted County, MN. Methods: Residents of Olmstad County, 
MN >45 years of age were randomly sampled to take part in a cross-sectional study of 
left ventricular function in a population. A detailed questionnaire, which included ques- 
tions pertaining to syncope, was administered to the participants of the parent study. 
Subjects were specifically asked to respond to the following question, "Have you ever 
experienced a black-out?" The prevalence of syncope was estimated as the number of 
self-reported cases divided by the number responding to the questionnaire. The associa- 
tion of syncope prevalence with patient characteristics was investigated using a chi- 
square test of independence for categorical data and a chi-squara test of trend for ordinal 
data. Results: A total of 1925 subjects responded to the questions related to syncope. 
The median age of the participants was 61 years (Q1=53, Q3=71) and 905 (47.0%) were 
male. Overall, 364 subjects reported an episode of syncope in their lifetime giving a 
crude estimated prevalence of 19% (95% CI: 17% to 21%). There was no statistically sig- 
nificant association of syncope prevalence with age (p=0.86). Females reported a higher 
prevalence of syncope (22% vs. 15%, p<0.01 ). The median age of onset of syncope was 
25 years (Q1=15, Q2=50) with 47% having at least one recurrence. Females tended to 
report more recurrent episodes of syncope than males (51% vs. 41%), but this was not 
